Companies / Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics, Inc.

NasdaqCIK 1937993PONTE VEDRA, FL

Financials

Revenue—
Net income$-13.24M
Total debt$829.7K
Cash$2.39M
Diluted EPS$-6.64
Shares outstanding2.9M

Ownership

2.9M shares outstanding · as of May 6, 2026
8.1%10%+ / strategic
Ownership
10%+ / strategic8.13%233,219
Institutions4.48%128,584
Public float87.39%2,506,444

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 0

View all →
Insider% of sharesShares
No insiders recorded yet.

Institutional holders 18

View all →
HolderValue% of shares
Vanguard Group Inc$365.5K1.88%
DRW Securities, LLC$170.5K0.88%
Geode Capital Management, LLC$110.7K0.75%
LPL Financial LLC$88.1K0.45%
JPMorgan Chase & Co$50.9K0.26%
BlackRock, Inc.$23.9K0.12%
Morgan Stanley$7.3K0.04%
UBS Group AG$7.1K0.04%
Tower Research Capital LLC (TRC)$3.6K0.02%
Osaic Holdings, Inc.$3.4K0.02%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
No activity matches these filters.

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
The PNC Financial Services Group, Inc.Passive13G—233,219—

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
———127636207—